Response to Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920.
Michael A NauckEskil KreinerSøren RasmussenHans A SaevereidJohn B Busenull nullPublished in: Diabetes care (2020)
Keyphrases
- cardiovascular events
- coronary artery disease
- liver failure
- cardiovascular disease
- respiratory failure
- drug induced
- aortic dissection
- double blind
- type diabetes
- clinical trial
- randomized controlled trial
- hepatitis b virus
- phase iii
- intensive care unit
- extracorporeal membrane oxygenation
- open label
- acute respiratory distress syndrome
- study protocol